Literature DB >> 19637104

The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers.

Ofra Sarid-Segal1, Clifford M Knapp, William Burch, Mark A Richardson, Sean Bahtia, Kimberly DeQuattro, Maryam Afshar, Courtney Richambault, Laurie Sickels, Eric Devine, Domenic A Ciraulo.   

Abstract

OBJECTIVE: The purpose of this study is to examine the effects of zonisamide on ethanol self-administration and subjective effects in risky drinkers using a human laboratory paradigm.
METHOD: We conducted a double-blind, placebo-controlled study of the effects of zonisamide 100 mg on ethanol self-administration and urge to drink in risky drinkers (N = 10) ( [1] ). RESULT: During the second hour of a 2-hour self-administration session ethanol consumption was 50% lower in the zonisamide group as compared to the placebo group. Urge to drink was also significantly lower under the zonisamide condition.
CONCLUSION: These results indicate that a single dose of zonisamide reduces urge to drink and the quantity of ethanol self-administered by risky drinkers during their second hour of access to alcohol. SCIENTIFIC SIGNIFICANCE: Zonisamide may help individuals drinking at risky levels reduce their intake of alcohol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19637104      PMCID: PMC4028067          DOI: 10.1080/00952990903060150

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  19 in total

1.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

Authors:  J T Sullivan; K Sykora; J Schneiderman; C A Naranjo; E M Sellers
Journal:  Br J Addict       Date:  1989-11

2.  Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations.

Authors:  L C Sobell; M B Sobell; G I Leo; A Cancilla
Journal:  Br J Addict       Date:  1988-04

3.  Development and initial validation of a measure of drinking urges in abstinent alcoholics.

Authors:  M J Bohn; D D Krahn; B A Staehler
Journal:  Alcohol Clin Exp Res       Date:  1995-06       Impact factor: 3.455

4.  Inhibitory effect of zonisamide on human carbonic anhydrase in vitro.

Authors:  Y Masuda; T Karasawa
Journal:  Arzneimittelforschung       Date:  1993-04

5.  Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior.

Authors:  Pia Bäckström; Petri Hyytiä
Journal:  Alcohol Clin Exp Res       Date:  2004-04       Impact factor: 3.455

6.  Development and validation of the Biphasic Alcohol Effects Scale.

Authors:  C S Martin; M Earleywine; R E Musty; M W Perrine; R M Swift
Journal:  Alcohol Clin Exp Res       Date:  1993-02       Impact factor: 3.455

7.  Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex.

Authors:  S Suzuki; K Kawakami; S Nishimura; Y Watanabe; K Yagi; M Seino; K Miyamoto
Journal:  Epilepsy Res       Date:  1992-06       Impact factor: 3.045

8.  Zonisamide enhances slow sodium inactivation in Myxicola.

Authors:  C L Schauf
Journal:  Brain Res       Date:  1987-06-09       Impact factor: 3.252

9.  The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies.

Authors:  R F Anton; D H Moak; P K Latham
Journal:  Arch Gen Psychiatry       Date:  1996-03

10.  Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons.

Authors:  Divina S Gryder; Michael A Rogawski
Journal:  J Neurosci       Date:  2003-08-06       Impact factor: 6.167

View more
  10 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

2.  Placebo-controlled trial of zonisamide for the treatment of alcohol dependence.

Authors:  Albert J Arias; Richard Feinn; Cheryl Oncken; Jonathan Covault; Henry R Kranzler
Journal:  J Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.153

3.  Voluntary intravenous self-administration of alcohol detects an interaction between GABAergic manipulation and GABRG1 polymorphism genotype: a pilot study.

Authors:  Martin H Plawecki; Leah Wetherill; Victor Vitvitskiy; Ann Kosobud; Ulrich S Zimmermann; Howard J Edenberg; Sean O'Connor
Journal:  Alcohol Clin Exp Res       Date:  2012-07-20       Impact factor: 3.455

Review 4.  Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders.

Authors:  Christopher J Hammond; Mark J Niciu; Shannon Drew; Albert J Arias
Journal:  CNS Drugs       Date:  2015-04       Impact factor: 5.749

5.  Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review.

Authors:  Jasmine Turna; Sabrina K Syan; Benicio N Frey; Brian Rush; Mary Jean Costello; Mark Weiss; James MacKillop
Journal:  Alcohol Clin Exp Res       Date:  2019-02-19       Impact factor: 3.455

Review 6.  State-of-the-art behavioral and pharmacological treatments for alcohol use disorder.

Authors:  Lara A Ray; Spencer Bujarski; Erica Grodin; Emily Hartwell; ReJoyce Green; Alexandra Venegas; Aaron C Lim; Artha Gillis; Karen Miotto
Journal:  Am J Drug Alcohol Abuse       Date:  2018-10-29       Impact factor: 3.829

7.  Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.

Authors:  Clifford M Knapp; Domenic A Ciraulo; Ofra Sarid-Segal; Mark A Richardson; Eric Devine; Chris C Streeter; Marlene Oscar-Berman; Caitlin Surprise; Laurie Colaneri; Meghan Putnam; Megan Waters; Courtney Richambault
Journal:  J Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.153

8.  Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence.

Authors:  Clifford M Knapp; Ofra Sarid-Segal; Mark A Richardson; Laurie Sickles Colaneri; Maryam Afshar; Eric Devine; Chris C Streeter; Joanne Piechniczek-Buczek; Domenic A Ciraulo
Journal:  Am J Drug Alcohol Abuse       Date:  2010-03       Impact factor: 3.829

9.  A Novel Sulfonamide, 4-FS, Reduces Ethanol Drinking and Physical Withdrawal Associated With Ethanol Dependence.

Authors:  Muhammad Sona Khan; Wulfran Trenet; Nancy Xing; Britta Sibley; Muzaffar Abbas; Mariya Al-Rashida; Khalid Rauf; Chitra D Mandyam
Journal:  Int J Mol Sci       Date:  2020-06-21       Impact factor: 5.923

Review 10.  PTSD and comorbid AUD: a review of pharmacological and alternative treatment options.

Authors:  Elizabeth Ralevski; Lening A Olivera-Figueroa; Ismene Petrakis
Journal:  Subst Abuse Rehabil       Date:  2014-03-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.